Compare Align Technology, Inc. (ALGN) vs Rocket Lab USA Inc (RKLB) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs Rocket Lab USA Inc — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while Rocket Lab USA Inc trades at $80.36 (market cap $50.64B). The key difference: Rocket Lab USA Inc is far larger — about 3.9× Align Technology, Inc.'s market cap, and Align Technology, Inc. is trading nearer its 52-week high, Rocket Lab USA Inc nearer its low. Which is the better fit depends on your goals.
| ALGN | RKLB | |
|---|---|---|
Market Cap | $12.86B | $50.64B |
Sector | Health | Technology |
52-Week High | $207.19 | $150.23 |
52-Week Low | $124.88 | $39.03 |
Enterprise Value | $11.92B | $49.39B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
Rocket Lab (RKLB) trades at $81.04, down 1.83% amid broader space sector weakness. The stock shows bearish technical signals with support at $77-$81 levels, while fundamentals reveal strong revenue growth ($602M in 2025) but persistent losses (-$198M net income). Recent news highlights the $8B Iridium acquisition and innovative 'Hungry Hippo' technology, positioning the company for long-term growth in the expanding space economy.
Analyst consensus remains bullish with a $119.10 price target (75% buy ratings), though profitability challenges and high valuations (P/S 66.26) present near-term risks. The company's expansion into satellite communications and defense contracts provides growth catalysts, but investors face volatility from sector-wide valuation concerns and execution risks on major acquisitions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Rocket Lab USA Inc
Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →
